Fajemirokun-Beck Olufunlayo Olurinde
Known title: DirectorCIK: 0001789821
Fajemirokun-Beck Olufunlayo Olurinde's purchase track record
Fajemirokun-Beck Olufunlayo Olurinde has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/15/2025 | FRPT | $20K | +21.1% | +43.6% | +1.3% |
| 2/26/2025 | FRPT | $25K | -25.4% | -46.2% | +8.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| FRPT | ▲ Buy | Grant | 1,589 | $0 | 3/10/2026 | View on chart |
| FRPT | ▲ Buy | Open Market | 378 | $20K | 9/15/2025 | View on chart |
| FRPT | ▲ Buy | Grant | 1,432 | $0 | 3/11/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 227 | $25K | 2/26/2025 | View on chart |
| FRPT | ▲ Buy | Grant | 1,095 | $0 | 3/15/2024 | View on chart |
| FRPT | ▲ Buy | Grant | 2,113 | $0 | 3/13/2023 | View on chart |
| FRPT | ▲ Buy | Grant | 1,422 | $0 | 3/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Freshpet Q2 Earnings Call Held; Wells Fargo Lowers Price Target
Freshpet held its Q2 2026 earnings call, a key event for investors tracking the pet food maker. Following the release, Wells Fargo maintained an Overweight rating but lowered its price target to $77. This adjustment places the bank's view below the current average analyst target of $84.25, reflecting a more cautious outlook on the stock's valuation.
Freshpet Q2 Earnings Call Held; Wells Fargo Lowers Price Target. Freshpet held its Q2 2026 earnings call, a key event for investors tracking the pet food maker. Following the release, Wells Fargo maintained an Overweight rating but lowered its price target to $77. This adjustment places the bank's view below the current average analyst target of $84.25, reflecting a more cautious outlook on the stock's valuation.